神经内镜微创手术对高血压脑出血患者 神经功能及术后生活质量的影响
CSTR:
作者:
作者单位:

(1. 广东同江医院,广东 佛山 528300;2. 佛山市第一人民医院,广东 佛山 528000;3. 佛山市第五人民医院, 广东 佛山 528000)

作者简介:

潘伟明,男,副主任医师,主要研究方向是颅脑和脊髓损伤、神经内镜治疗技术。

通讯作者:

中图分类号:

R 743.3

基金项目:

佛山市科技计划项目(1920001000328)


Effect of Neuroendoscopic Minimally Invasive Surgery on Neurological Function and Postoperative Quality of Life in Patients with Hypertensive Intracerebral Hemorrhage
Author:
Affiliation:

(1. Guandong Tongjiang Hospital, Guangdong Foshan 528300; 2. Foshan First People's Hospital, Guangdong Foshan 528000; 3. Foshan Fifth People's Hospital, Guangdong Foshan 528000)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    〔摘 要〕 目的:分析神经内镜微创手术和常规小骨窗开颅血肿清除术对高血压脑出血患者神经功能及术后生活质 量的影响,以得出更佳的治疗方案。方法:选取广东同江医院及佛山市第一人民医院 2020 年 4 月至 2021 年 4 月收治 的 100 例高血压脑出血患者,随机分为观察组和对照组,各 50 例。对照组给予常规小骨窗开颅血肿清除术治疗,观 察组给予神经内镜微创手术治疗,比较两组患者的各项疗效。结果:治疗后两组患者的美国国立卫生研究院卒中量表 (NIHSS)评分均有不同程度下降,日常生活活动量表(ADL)、格拉斯哥昏迷量表(GCS)、格拉斯哥预后评分(GOS) 评分均有不同程度上升,且观察组患者的 NIHSS 评分低于对照组,ADL 评分高于对照组,GCS 评分高于对照组, GOS 评分高于对照组,差异具有统计学意义(P < 0.05)。观察组患者的手术时间短于对照组,术中出血量少于对照组, 住院时间短于对照组,血肿清除率高于对照组,差异具有统计学意义(P < 0.05)。随访 6 个月,观察组患者有 1 例 (2.0 %)再出血,与对照组的 2 例(4.0 %)比较,差异无统计学意义(P > 0.05)。随访 6 个月,观察组患者的并 发症发生率为 8.0 %,低于对照组的 32.0 %,差异具有统计学意义(P < 0.05)。结论:高血压脑出血治疗中,神经 内镜微创手术较常规小骨窗开颅血肿清除术能更有效地改善患者神经功能及术后生活质量。

    Abstract:

    〔Abstract〕 Objective To analyze the effects of neuroendoscopic minimally invasive surgery and conventional small bone window craniotomy hematoma removal on neurological function and postoperative quality of life in patients with hypertensive intracerebral hemorrhage, so as to obtain a better treatment plan. Methods 100 patients with hypertensive intracerebral hemorrhage from April 2020 to April 2021 were selected and divided into the observation group and the control group, with 50 cases in each group. The control group was treated with conventional small bone window craniotomy for hematoma removal, and the observation group was treated with neuroendoscopic minimally invasive surgery, and the curative effects of the two groups were compared. Results After treatment, the scores of the National Institutes of Health Stroke Scale (NIHSS) in the two groups decreased to varying degrees, while the activities of daily living scale (ADL), glasgow coma scale (GCS) and glasgow prognosis score (GOS) increased to varying degrees. The NIHSS score in the observation group was lower than that in the control group, and the ALD score, GCS score and GOS score in the observation group were higher than those in the control group, and the differences were statistically significant (P < 0.05). The operation time of the observation group was shorter than that of the control group, the amount of intraoperative blood loss of the observation group was less than that of the control group, the length of hospitalization of the observation group was shorter than that of the control group, and the hematoma clearance rate of the observation group was higher than that of the control group, all with statistical significances (P < 0.05). After 6 months of follow-up, there was 1 case (2.0 %) of rebleeding in the observation group, compared with 2 cases (4.0 %) in the control group, and there was no statistical significance (P > 0.05). After 6 months of follow-up, the incidence of complications in the observation group was 8.0%, lower than 32.0 % in the control group , and the difference was statistically significant (P < 0.05). Conclusion In the treatment of hypertensive intracerebral hemorrhage, neuroendoscopic minimally invasive surgery is more effective than conventional small bone window craniotomy hematoma removal in improving neurological function and postoperative quality of life.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-11-01
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-04-18
  • 出版日期:
文章二维码
特别声明

近期有不法分子冒充我刊名义给作者打电话或发邮件,编造各种理由要求添加微信或QQ、伪造复制我刊编辑部公章发放假冒录用通知书等等各种方式试图骗取作者钱财。为强化编辑部工作规范,加强单位公章管理,维护作者的正当权益和财产利益, 我刊在此郑重声明:(1)编辑部与作者沟通方式为电话和邮件,在本刊唯一官方网站(http:/szzxyjhzz.szrch.com)“联系我们”下拉菜单,或者网站最下端信息栏可以查询),绝对不会要求作者添加微信或QQ。 (2)自2025年2月1日起,注销废除“深圳中西医结合杂志编辑部”电子公章;我刊稿件录用通知调整为加盖编辑部实体公章的纸质文件或其扫描件,录用稿件仅收取合理版面制作费和审稿费,收款单位为“深圳市第二人民医院”对公账户,其他加盖电子公章或涉及私人账户者均为伪造假冒。望广大作者提高警惕,谨防上当受骗。 《深圳中西医结合杂志》编辑部

关闭